Results 91 to 100 of about 1,359 (119)

C1-inactivator is upregulated in glioblastoma. [PDF]

PLoS One, 2017
Förnvik K, Maddahi A, Persson O, Osther K, Salford LG, Nittby Redebrandt H.   +5 more
europepmc   +1 more source

Proteomic profiling of mesenchymal stem cell-derived extracellular vesicles: Impact of isolation methods on protein cargo. [PDF]

J Extracell Biol
Abyadeh M, Mirshahvaladi S, Kashani SA, Paulo JA, Amirkhani A, Mehryab F, Seydi H, Moradpour N, Jodeiryjabarzade S, Mirzaei M, Gupta V, Shekari F, Salekdeh GH.   +12 more
europepmc   +1 more source

Recurrent Acute Abdomen as the Main Manifestation of Hereditary Angioedema. [PDF]

Intern Med, 2019
Iwanami K, Okano T, Ohara O, Morio T.
europepmc   +1 more source

Development and Prospects of Furin Inhibitors for Therapeutic Applications. [PDF]

Int J Mol Sci
Ivachtchenko AV, Khvat AV, Shkil DO.
europepmc   +1 more source

Does Complement Have a Role in the Pathogenesis of Alopecia Areata? [PDF]

Skin Appendage Disord, 2018
Juhász MLW, Atanaskova Mesinkovska N.
europepmc   +1 more source

Overview of Venous Thromboembolism and Emerging Therapeutic Technologies Based on Nanocarriers-Mediated Drug Delivery Systems. [PDF]

Molecules
Salavati M, Arabshomali A, Nouranian S, Shariat-Madar Z.   +3 more
europepmc   +1 more source

Characterization of turkey complement and its role in defense against Escherichia coli infection [PDF]

, 1987
Ellis, Marlene Gail
core   +2 more sources

Enzyme promiscuity in the field of synthetic biology applied to white biotechnology: Opportunities and weaknesses. [PDF]

Biodes Res
Malfoy T, Alkim C, François JM.
europepmc   +1 more source

An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas. [PDF]

Curr Treat Options Oncol
Stergiopoulos GM, Concilio SC, Galanis E.   +2 more
europepmc   +1 more source

ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM

Journal of Experimental Medicine, 1969
Robert Schreiber
exaly